Author: Katrina Megget

Thirty-three European countries have been heads down for almost two years setting the scene for what will be one of pharma’s most coming-of-age transformations – releasing the intimate (and potentially uncomfortable) details of exactly which doctors have been paid by which pharma companies, what for and how much. Driven through by the European trade body EFPIA, the move, which came into force on 1 January this year, marks the societal shift and expectation that big pharma has no alternative now but to embrace transparency. 

Healthcare is proving to be one of the biggest adopters of virtual reality, outside the gaming industry.

The world of robotics has started to change.

Drugs giant Pfizer has not ruled out a merger abroad to take advantage of low tax rates, despite the US clampdown on the tax inversion loophole.

Healthcare is entering a “biomedical revolution” and medicine will change beyond recognition, a leading health expert has said.